drugset / Trial / NCT06879132

A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fed Conditions

NCT06879132 ↗

Phase 1 Completed 40 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this clinical study is to evaluate the pharmacokinetics and safety of BR3409 and co-administration of BR3409-1 and BR3409-2 in healthy volunteers Under Fed Conditions

Timeline

Start
2024-11-05
Primary completion
2024-12-07
Completion
2024-12-07

Drugs

EvaluationDrugModalityDoseRoute
Subject BR3409 Unknown — —
Comparator BR3409-1 Unknown — —
Comparator BR3409-2 Unknown — —